14/07/2026
Congratulations 🎉🎊
Founded in 2007, Aryakul blends cutting-edge pharmaceutical education with a deep focus on sustainability and social impact.
We nurture innovation, excellence, and community responsibility. At Aryakul, learning is a journey of shaping a better future.
14/07/2026
Congratulations 🎉🎊
13/07/2026
Advancing Pharmaceutical Pedagogy: Digital Alternatives in Experimental Pharmacology. Faculty Development Programme (FDP) session,Lecture-04 We are pleased to share that the Aryakul College of Pharmacy & Research, Lucknow successfully hosted a comprehensive Faculty Development Programme (FDP) session,Lecture-04 led by our expert faculty member, Principal (ACPR Lucknow) Dr. Aditya Singh on "Experimental Pharmacology: Software, Application, and Hands-on Training," focused on bridging the gap between traditional methodologies and modern digital simulations. As academic institutions globally transition towards more sustainable and ethically compliant frameworks, integrating simulation tools like ExPharm software has become crucial.
Dr. Singh provided our faculty with critical insights into,experimental pharmacology,virtual dose-response curve profiling, simulated drug screenings, and regulatory compliance aligned with PCI standards.All Faculties and Researchers learned the applications of software and its uses.As we come to successfull completion of FDP, vote of thanks was delivered by Mr. B K Singh, Head of the Dept, ACPR Lucknow,to the management, organizing team,faculty members of the department,and faculties of ACPR Sitapur,& ACPR Raebareli.
13/07/2026
Congratulations 🎉
11/07/2026
Congratulations 🎉
10/07/2026
💐💐
10/07/2026
*CSIR-CDRI Symposium*
M.Pharm students of Aryakul College of Pharmacy & Research (ACPR), Lucknow—Ms. Bandita Das, Ms. Nicey Jee, and Ms. Anchal Yadav—participated in the prestigious " *Innovations in Medicine: Symposium for and by the Students" organized by CSIR–Central Drug Research Institute (CSIR-CDRI), Lucknow* on 09 July 2026.
The symposium featured scientific sessions on Vepdegestrant, the first FDA-approved PROTAC therapy for breast cancer, and Zoliflodacin, a novel oral antibiotic for combating antimicrobial resistance. Students gained valuable exposure to recent advances in drug discovery and interacted with leading scientists and researchers from CSIR-CDRI.
*ACPR continues to encourage participation in national-level scientific programmes to strengthen research skills, scientific temperament, and innovation-driven learning in line with the objectives of NEP 2020.*
._APJ_Abdul_Kalam_Technical_University
| Monday | 9:30am - 5pm |
| Tuesday | 9:30am - 5pm |
| Wednesday | 9:30am - 5pm |
| Thursday | 9:30am - 5pm |
| Friday | 9:30am - 5pm |
| Saturday | 9:30am - 5pm |
| Sunday | 10am - 1pm |